Five-Year Clinical Follow-Up After Implantation of the Endeavor Zotarolimus-Eluting Stent: ENDEAVOR I, First-in-Human Study

Ian T Meredith; John Ormiston; Robert Whitbourn; I Patrick Kay; David Muller; Donald E Cutlip

Journal article

Five-Year Clinical Follow-Up After Implantation of the Endeavor Zotarolimus-Eluting Stent: ENDEAVOR I, First-in-Human Study

Ian T Meredith, John Ormiston, Robert Whitbourn, I Patrick Kay, David Muller, Donald E Cutlip

Catheterization and Cardiovascular Interventions | WILEY | Published : 2009

DOI: 10.1002/ccd.22206

University of Melbourne Researchers

Robert Whitbourn Author Medicine - St Vincent's Hospital

Grants

Funding Acknowledgements

Conflict of interest: Prof. Ian T. Meredith serve as a consultant to Boston Scientific and Medtronic CardioVascular. Dr. Ormiston serves on advisory boards for Abbott Vascular and Boston Scientific. Dr. Whitbourn has received research/grant support from Abbott Vascular, Boston Scientific, and Medtronic CardioVascular. Dr. Muller has received research/grant support from Abbott Vascular and Medtronic CardioVascular. Dr. Kay and Dr. Cutlip have no conflicts to report.